Rua concludes Medbloom agreement, develops new opportunity

GENERAL
Wed, May 12 2021 02:09 pm

A commercial agreement between Rua Bioscience (NZX: RUA) and Medbloom Limited to supply raw biomass has been concluded by mutual understanding. Rua is now focused on progressing existing discussions with alternative grower partners to supplement the company's existing cultivation facility in Ruatorea.

The conclusion of this agreement will not delay Rua's first export revenue.

In October 2020, Medbloom (a subsidiary of Blooming Hill Flowers) signed a commercial agreement to grow and supply Rua with cannabis plant material - with production expected to begin in 2022. The agreement was contingent upon Medbloom securing adequate capital to expand its operation.

Though disappointed, Rua CEO Rob Mitchell says Rua is well-placed to fill the gap.

Rua is in advanced discussions with a number of other grower partners already producing biomass, with strong horticultural experience and the capability to deliver the volumes needed. There is significant scope for partnership opportunity in the evolving New Zealand industry. Rua understands Medsafe has issued 27 commercial licences under the medicinal cannabis scheme. Other growers will provide the geographical diversification originally offered by Medbloom, safeguarding Rua from potential environmental and other external factors that may affect production.



For more information, please visit www.ruabio.com or contact:
Kerry Donovan
Communications Manager
Rua Bioscience
M 021 128 7689
[email protected]


About Rua Bioscience
Rua Bioscience is a New Zealand pharmaceutical company aiming to be a leading producer of cannabinoid derived medicines for both export and local markets. Rua has been an early mover in the sector and was the first private company in New Zealand to receive a licence to cultivate cannabis for research purposes. Founded in 2017 in Ruatorea as a subsidiary of charitable company Hikurangi Enterprises Limited, Rua is underpinned by its mission to heal the people and heal the land. It is committed to New Zealand’s Te Tairāwhiti (East Coast) region and its connection with its local community. The company has completed facilities for cultivation and manufacturing.
www.ruabio.com


Announcement PDF


Markets News

NZ sharemarket up nearly 1% amid ongoing takeover drama
Markets Market close

NZ sharemarket up nearly 1% amid ongoing takeover drama

The S&P/NZX 50 Index closed at 12,425.58, up 115.67 points or 0.94%.

Graham Skellern 23 Jul 2024
Markets

ForBarr downgrades Genesis on gas uncertainty

The company faced the greatest challenges in the sector. 

Ian Llewellyn 23 Jul 2024
ForBarr downgrades Genesis on gas uncertainty
Markets Analysis

The Warehouse takeover could be the first of many

Investors may not be showing NZ firms love, but private equity will.

The Warehouse takeover could be the first of many